The Centers for Disease Control and Prevention plans to award a sole source contract to Columbia University for laboratory analyses and collaborative research on micro- and nanoplastics (MNPs), focusing on protocol validation and measurement variability in biological matrices. The performance period is from September 15, 2026, through September 14, 2028. No budget amount is specified. Work will be performed at the contractor’s location, with integration of CDC expertise. This notice is not a competitive solicitation, but interested parties may submit capability responses for consideration.